lung cancer
Conditions
Interventions
Experimental group1:video-assisted thoracic surgery
Experimental group2:robot-assisted thoracic surgery
Sponsors
The Affiliated Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.The patient's age is 18 years or older; 2.Performance status of ECOG 0-1; 3.Lung cancer patients were diagnosed by biopsy and histology; 4.Stage cIB-III (8th TNM staging standard) was confirmed by bronchoscopy, CT guided puncture biopsy, PET-CT or chest CT enhancement and so on; 5.No previous history of chemotherapy or radiotherapy before diagnosis; 6.Radical resection of lung cancer can be achieved under direct vision 7.Hematological and biochemical indexes showed no obvious abnormalities; 8.No serious concomitant diseases affecting survival within 5 years 9.Agree and be able to comply with the study protocol and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Pregnancy or lactation; 2.No controlled seizures, central nervous system diseases or mental disorders; 3.History of thoracic surgery; 4.Other malignant diseases within 5 years; 5.There are any signs of distant metastasis; 6.Clinically serious or active heart disease, such as symptomatic coronary heart disease, congestive heart failure of New York Heart Association (NYHA) grade II or above, severe arrhythmia or myocardial infarction within 6 months; 7.Cerebral hemorrhage or infarction within 6 months; 8.Organ transplant recipients receiving immunosuppressive therapy; 9.Severe recurrent infection or other serious concomitant diseases; 10.Other diseases requiring simultaneous surgery; 11.Emergency surgery is required due to tumor emergencies (such as bleeding); 12.Patients participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year overall survival;5-year disease free survival;Cost; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-year overall survival;3-year disease free survival;Operative time;Blood loss;Conversion rate;R0 resection rate;Perioperative complication;Operative death rate;Length of stay in hospital;Chest tube drainage time;lymph node resection;Pain score; | — |
Countries
China
Contacts
Public ContactJiao Wenjie
The Affiliated Hospital of Qingdao University
Outcome results
None listed